Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Item

http://www.wikidata.org/entity/Q33719962

Q33719962

about

Dynamic Contrast-Enhanced MRI to Study Atherosclerotic Plaque Microvasculature Imaging and nanomedicine in inflammatory atherosclerosis Vascular disease in cocaine addiction.18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Relationship between particulate matter exposure and atherogenic profile in "Ground Zero" workers as shown by dynamic contrast enhanced MR imaging.Positron emission tomography imaging of coronary atherosclerosis.Cardiovascular defense challenges at the basic, clinical, and population levels The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Registration of dynamic contrast-enhanced MRI of the common carotid artery using a fixed-frame template-based squared-difference method.New horizons for cholesterol ester transfer protein inhibitors.Inflammatory markers in coronary artery disease.An update on the clinical development of dalcetrapib (RO4607381), a cholesteryl ester transfer protein modulator that increases HDL cholesterol levels.Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification.Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis.Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach.Atherosclerosis imaging using 3D black blood TSE SPACE vs 2D TSE.SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis.Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials.18F-Sodium Fluoride Uptake in Abdominal Aortic Aneurysms: The SoFIA3 Study.

P2860

Q26749689-2CC05E6F-04E1-436E-B70B-F44811AE32BA Q27002916-E8E479A5-5C58-4457-B9DA-B4D46EBCED2C Q30235010-0DB5EFAF-F0FE-4F28-92DF-7A38FF1BC298 Q30842993-AB578E87-7B21-441F-98DD-BB03EDC9BDFE Q33624365-0A4FABAF-E433-48E6-814D-9E6704F2D6A2 Q33956714-AA91FA3D-8629-4388-B084-145850181223 Q34120778-E49C5A8D-6B70-4836-8865-FBE0BDB7BB38 Q36824109-F6B4549B-020F-4CCD-890D-DDE8637AAF27 Q37050963-77FFA876-FB17-45BE-B5E6-E6773C6CB2BC Q37118290-C84DC393-B2A1-426E-B5DF-34700D1CE63B Q37296851-41212029-F986-41FE-9A42-2E11D42C11C2 Q37720649-9D1B7555-FEE4-486F-9A48-0E5C400E221B Q37956122-008B831E-61BA-436D-BB95-4A8037B9B2C2 Q38013061-CF36CB02-6391-4DD6-B2EF-985A4D314AC3 Q38032616-E94F65E6-28EB-401F-A666-AC08A28D16B5 Q38043973-F0D74D43-EAE7-4186-A5FE-5F02FB82F91E Q38094125-732E6D8B-B92A-4BFC-93C5-F595DA266925 Q38397910-CDB08FD6-F2A7-41B6-8C1D-D4BBD68037BD Q38605303-0F3C74E8-9525-4CFA-8421-06552AF1DD80 Q39185553-BE6FB000-2DD8-4394-A994-BAE48FF637C2 Q40028808-FF309011-7E6E-4BF3-BE11-140BF5AB754F Q41238952-3E27B869-8093-4D7C-A3A0-B927C659613F Q42701584-9CED7928-AC50-4D1B-9F1D-CFD4FBDEB864 Q47158087-E565E980-1119-4349-84EF-D0433C20D54B Q50181028-45840AEE-5880-4D16-B9D9-FC7A35FD6C26

P2860

Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography

Item

http://www.wikidata.org/entity/Q33719962

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu